Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA)

CUSIP: 45826J105

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
116,932,531
Total 13F shares
104,126,444
Share change
-404,934
Total reported value
$936,116,134
Put/Call ratio
68%
Price per share
$8.99
Number of holders
289
Value change
-$52,721,966
Number of buys
151
Number of sells
135

Quarterly Holders Quick Answers

What is CUSIP 45826J105?
CUSIP 45826J105 identifies NTLA - Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) as of Q4 2025

As of 31 Dec 2025, Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) was held by 289 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 104,126,444 shares. The largest 10 holders included ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, D. E. Shaw & Co., Inc., REGENERON PHARMACEUTICALS, INC., TWO SIGMA INVESTMENTS, LP, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, and MORGAN STANLEY. This page lists 289 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.